Shaolei Lu, Ph.D. - Publications

Affiliations: 
2006 University of Massachusetts, Amherst, Amherst, MA 
Area:
Molecular Biology, Genetics

27 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Yakirevich E, Pavlick DC, Perrino CM, Stanton M, Lu S, Carneiro B, Bratslavsky G, Ross JS. NF2 Tumor Suppressor Gene Inactivation in Advanced Papillary Renal Cell Carcinoma. The American Journal of Surgical Pathology. PMID 32925192 DOI: 10.1097/Pas.0000000000001586  0.307
2020 Bai X, Zhang H, Zhou Y, Nagaoka K, Meng J, Ji C, Liu D, Dong X, Cao K, Mulla J, Cheng Z, Mueller W, Bay A, Hildebrand G, Lu S, et al. TET1 promotes malignant progression of cholangiocarcinoma with IDH1 wild-type. Hepatology (Baltimore, Md.). PMID 32740973 DOI: 10.1002/Hep.31486  0.352
2019 Lu S, Yakirevich E, Wang LJ, Resnick MB, Wang Y. Cytokeratin 7-negative and GATA binding protein 3-negative breast cancers: Clinicopathological features and prognostic significance. Bmc Cancer. 19: 1085. PMID 31718619 DOI: 10.1186/S12885-019-6295-8  0.304
2019 Zhao CL, Singh K, Brodsky AS, Lu S, Graves TA, Fenton MA, Yang D, Sturtevant A, Resnick MB, Wang Y. Stromal ColXα1 expression correlates with tumor-infiltrating lymphocytes and predicts adjuvant therapy outcome in ER-positive/HER2-positive breast cancer. Bmc Cancer. 19: 1036. PMID 31675929 DOI: 10.1186/S12885-019-6134-Y  0.319
2018 Hui Y, Lu S, Wang H, Resnick MB, Wang Y. Discordant HER2 Immunohistochemical Expression and Gene Amplification in Ductal Carcinoma In Situ - Evaluating HER2 in Synchronous In Situ and Invasive Carcinoma. Histopathology. PMID 30117181 DOI: 10.1111/His.13731  0.345
2018 Huang CK, Iwagami Y, Zou J, Casulli S, Lu S, Nagaoka K, Ji C, Ogawa K, Cao KY, Gao JS, Carlson RI, Wands JR. Aspartate beta-hydroxylase promotes cholangiocarcinoma progression by modulating RB1 phosphorylation. Cancer Letters. PMID 29733964 DOI: 10.1016/J.Canlet.2018.04.041  0.342
2017 Zhao CL, Hui Y, Wang LJ, Lombardo K, Yang D, Mangray S, Yakirevich E, Amin A, Huang CK, Lu S. T-complex-associated-testis-expressed 3 (TCTE3) is a Novel Marker for Pancreatobiliary Carcinomas. Human Pathology. PMID 29079176 DOI: 10.1016/J.Humpath.2017.10.010  0.355
2017 Yakirevich E, Lu S, Allen D, Mangray S, Fanion JR, Lombardo KA, Safran H, Resnick MB. Prognostic Significance of IgG4+ Plasma Cell Infiltrates Following Neoadjuvant Chemoradiation Therapy for Esophageal Adenocarcinoma. Human Pathology. PMID 28666927 DOI: 10.1016/J.Humpath.2017.06.009  0.347
2016 Wood SM, Gill AJ, Brodsky AS, Lu S, Friedman K, Karashchuk G, Lombardo K, Yang D, Resnick MB. Fatty acid-binding protein 1 is preferentially lost in microsatellite instable colorectal carcinomas and is immune modulated via the interferon γ pathway. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. PMID 27687006 DOI: 10.1038/Modpathol.2016.170  0.397
2016 Wang Y, Resnick MB, Lu S, Hui Y, Brodsky AS, Yang D, Yakirevich E, Wang L. Collagen Type III alpha1 as a useful diagnostic immunohistochemical marker for fibroepithelial lesions of the breast. Human Pathology. PMID 27498063 DOI: 10.1016/J.Humpath.2016.07.017  0.348
2016 Li J, Lu S, Lombardo K, Monahan R, Amin A. ARID1A alteration in aggressive urothelial carcinoma and variants of urothelial carcinoma. Human Pathology. PMID 27137986 DOI: 10.1016/J.Humpath.2016.04.006  0.368
2016 Friedman K, Brodsky AS, Lu S, Wood S, Gill AJ, Lombardo K, Yang D, Resnick MB. Medullary carcinoma of the colon: a distinct morphology reveals a distinctive immunoregulatory microenvironment. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. PMID 26965581 DOI: 10.1038/Modpathol.2016.54  0.365
2015 Yakirevich E, Magi-Galluzzi C, Grada Z, Lu S, Resnick MB, Mangray S. Cadherin 17 is a sensitive and specific marker for metanephric adenoma. The American Journal of Surgical Pathology. 39: 479-86. PMID 25768256 DOI: 10.1097/Pas.0000000000000401  0.336
2015 Snow AN, Mangray S, Lu S, Clubwala R, Li J, Resnick MB, Yakirevich E. Expression of cadherin 17 in well-differentiated neuroendocrine tumours. Histopathology. 66: 1010-21. PMID 25388236 DOI: 10.1111/His.12610  0.339
2013 Taliano RJ, Lu S, Singh K, Mangray S, Tavares R, Noble L, Resnick MB, Yakirevich E. Calretinin expression in high-grade invasive ductal carcinoma of the breast is associated with basal-like subtype and unfavorable prognosis. Human Pathology. 44: 2743-50. PMID 24262018 DOI: 10.1016/J.Humpath.2013.07.021  0.432
2013 Matoso A, Mukkada VA, Lu S, Monahan R, Cleveland K, Noble L, Mangray S, Resnick MB. Expression microarray analysis identifies novel epithelial-derived protein markers in eosinophilic esophagitis. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 26: 665-76. PMID 23503644 DOI: 10.1038/Modpathol.2013.41  0.408
2013 Lu S, Singh K, Mangray S, Tavares R, Noble L, Resnick MB, Yakirevich E. Claudin expression in high-grade invasive ductal carcinoma of the breast: correlation with the molecular subtype. Modern Pathology : An Official Journal of the United States and Canadian Academy of Pathology, Inc. 26: 485-95. PMID 23222490 DOI: 10.1038/Modpathol.2012.187  0.406
2012 Cellurale C, Girnius N, Jiang F, Cavanagh-Kyros J, Lu S, Garlick DS, Mercurio AM, Davis RJ. Role of JNK in mammary gland development and breast cancer. Cancer Research. 72: 472-81. PMID 22127926 DOI: 10.1158/0008-5472.Can-11-1628  0.343
2012 Yakirevich E, Samkari A, Holloway MP, Lu S, Singh K, Yu J, Fenton MA, Altura RA. Total Survivin and acetylated Survivin correlate with distinct molecular subtypes of breast cancer. Human Pathology. 43: 865-73. PMID 22055399 DOI: 10.1016/J.Humpath.2011.07.014  0.407
2011 Goel HL, Bae D, Pursell B, Gouvin LM, Lu S, Mercurio AM. Neuropilin-2 promotes branching morphogenesis in the mouse mammary gland. Development (Cambridge, England). 138: 2969-76. PMID 21693513 DOI: 10.1242/Dev.051318  0.313
2011 Yakirevich E, Lu S, Samkari A, Singh K, Holloway M, Altura RA. Abstract 2272: Survivin and acetylated Survivin predict outcome in breast cancer and correlate separately with a basal-like and luminal-type expression profile Cancer Research. 71: 2272-2272. DOI: 10.1158/1538-7445.Am2011-2272  0.413
2009 Walter O, Prasad M, Lu S, Quinlan RM, Edmiston KL, Khan A. IMP3 is a novel biomarker for triple negative invasive mammary carcinoma associated with a more aggressive phenotype. Human Pathology. 40: 1528-33. PMID 19695680 DOI: 10.1016/J.Humpath.2009.05.005  0.431
2009 Yang X, Pursell B, Lu S, Chang TK, Mercurio AM. Regulation of beta 4-integrin expression by epigenetic modifications in the mammary gland and during the epithelial-to-mesenchymal transition. Journal of Cell Science. 122: 2473-80. PMID 19549682 DOI: 10.1242/Jcs.049148  0.341
2008 Bae D, Lu S, Taglienti CA, Mercurio AM. Metabolic stress induces the lysosomal degradation of neuropilin-1 but not neuropilin-2. The Journal of Biological Chemistry. 283: 28074-80. PMID 18708346 DOI: 10.1074/Jbc.M804203200  0.311
2008 Lu S, Becker KA, Hagen MJ, Yan H, Roberts AL, Mathews LA, Schneider SS, Siegelmann HT, MacBeth KJ, Tirrell SM, Blanchard JL, Jerry DJ. Transcriptional responses to estrogen and progesterone in mammary gland identify networks regulating p53 activity. Endocrinology. 149: 4809-20. PMID 18556351 DOI: 10.1210/En.2008-0035  0.665
2008 Lu S, Simin K, Khan A, Mercurio AM. Analysis of integrin beta4 expression in human breast cancer: association with basal-like tumors and prognostic significance. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 14: 1050-8. PMID 18281537 DOI: 10.1158/1078-0432.Ccr-07-4116  0.372
2005 Becker KA, Lu S, Dickinson ES, Dunphy KA, Mathews L, Schneider SS, Jerry DJ. Estrogen and progesterone regulate radiation-induced p53 activity in mammary epithelium through TGF-beta-dependent pathways. Oncogene. 24: 6345-53. PMID 15940247 DOI: 10.1038/Sj.Onc.1208787  0.657
Show low-probability matches.